Controversies in altitude medicine

Travel Medicine and Infectious Disease

Volumn 3, Issue 4 SPEC. ISS., 2005, Pages 183-188

  Dumont, Lionel ^a   Lysakowski, Christopher ^a   Tramèr, Martin R ^a   Kayser, Bengt ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Acetazolamide; Acute mountain sickness; Cerebral blood flow

Indexed keywords

ACETAZOLAMIDE; DEXAMETHASONE; PLACEBO;

ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; BRAIN EDEMA; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DOSE RESPONSE; DRUG EFFICACY; HUMAN; HYPOBARISM; HYPOXIA; LOW DRUG DOSE; META ANALYSIS; METHODOLOGY; MIDDLE CEREBRAL ARTERY; MOUNTAINEERING; PARESTHESIA; PATHOGENESIS; POLYURIA; PREDICTION; PREVENTIVE MEDICINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; RISK REDUCTION; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TRAVEL; VASOSPASM;

EID: 24344496545     PISSN: 14778939     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmaid.2004.12.001     Document Type: Article

References (32)

1. F. Berghold Drug abuse in the mountains Health and height proceedings of the fifth world congress on mountain medicine and high altitude physiology 2003 Publicaciones de la Universitat de Barcelona Barcelona p. 99-106
2. Gaillard S, Dellasanta P, Loutan L, Kayser B. Awareness, prevalence, medication use and risk factors of acute mountain sickness in tourists trekking around the Annapurnas in Nepal: A 12 yr follow-up. High Alt Med Biol 2004;5(4):410-9.
3. P.H. Hackett R.C. Roach High-altitude illness N Engl J Med 345 2 2001 107-114
4. L. Dumont C. Mardirosoff M.R. Tramèr Efficacy and harm of pharmacological prevention of acute mountain sickness: Quantitative systematic review BMJ 321 7256 2000 267-272
5. A. Moore J. Edwards J. Barden H.J. McQuay Bandolier's little book of pain. An evidence-based guide to treatments 2003 Oxford University Press Oxford
6. J.B. West Acetazolamide dose and acute mountain sickness BMJ 2001 http://bmj.bmjjournals.com/cgi/content/full/321/7256/267
7. P. Hackett P. Bartsch M. Schneider L. Dumont M.R. Tramèr C. Mardirosoff Pharmacological prevention of acute mountain sickness BMJ 322 7277 2001 48
8. B. Basnyat J.H. Gertsch E.W. Johnson F. Castro-Marin Y. Inoue C. Yeh Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: A prospective, double-blind, randomized, placebo-controlled trial High Alt Med Biol 4 1 2003 45-52
9. J.H. Gertsch B. Basnyat E.W. Johnson J. Onopa P.S. Holck Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: The prevention of high altitude illness trial (PHAIT) BMJ 328 7443 2004 797
10. C. Carlsten E.R. Swenson S. Ruoss A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m) High Alt Med Biol 5 1 2004 33-39
11. E. Garrido A. Castello J.L. Ventura A. Capdevila F.A. Rodriguez Cortical atrophy and other brain magnetic resonance imaging (MRI) changes after extremely high-altitude climbs without oxygen Int J Sports Med 14 4 1993 232-234
12. J.H. Jeong J.C. Kwon J. Chin S.J. Yoon D.L. Na Globus pallidus lesions associated with high mountain climbing J Korean Med Sci 17 6 2002 861-863
13. J.B. West Do climbs to extreme altitude cause brain damage? Lancet 2 8503 1986 387-388
14. M. Regard O. Oelz P. Brugger T. Landis Persistent cognitive impairment in climbers after repeated exposure to extreme altitude Neurology 39 2 Pt 1 1989 210-213
15. G. Cavaletti R. Moroni P. Garavaglia G. Tredici Brain damage after high-altitude climbs without oxygen Lancet 1 8524 1987 101
16. M. Anooshiravani L. Dumont C. Mardirosoff G. Soto-Debeuf J. Delavelle Brain magnetic resonance imaging (MRI) and neurological changes after a single high altitude climb Med Sci Sports Exerc 31 7 1999 969-972
17. J.B. Jensen A.D. Wright N.A. Lassen T.C. Harvey M.H. Winterborn M.E. Raichle et al. Cerebral blood flow in acute mountain sickness J Appl Physiol 69 2 1990 430-433
18. T.C. Harvey M.E. Raichle M.H. Winterborn J. Jensen N.A. Lassen N.V. Richardson et al. Effect of carbon dioxide in acute mountain sickness: A rediscovery Lancet 2 8612 1988 639-641
19. P. Horn P. Vajkoczy C. Thome E. Muench L. Schilling P. Schmiedek Xenon-induced flow activation in patients with cerebral insult who undergo xenon-enhanced CT blood flow studies AJNR Am J Neuroradiol 22 8 2001 1543-1549
20. J.M. Valdueza J.O. Balzer A. Villringer T.J. Vogl R. Kutter K.M. Einhaupl Changes in blood flow velocity and diameter of the middle cerebral artery during hyperventilation: Assessment with MR and transcranial Doppler sonography AJNR Am J Neuroradiol 18 10 1997 1929-1934
21. E.B. Ringelstein S. Van Eyck I. Mertens Evaluation of cerebral vasomotor reactivity by various vasodilating stimuli: Comparison of CO2 to acetazolamide J Cereb Blood Flow Metab 12 1 1992 162-168
22. S.M. Otis M.E. Rossman P.A. Schneider M.P. Rush E.B. Ringelstein Relationship of cerebral blood flow regulation to acute mountain sickness J Ultrasound Med 8 3 1989 143-148
23. R.W. Baumgartner P. Bartsch M. Maggiorini U. Waber O. Oelz Enhanced cerebral blood flow in acute mountain sickness Aviat Space Environ Med 65 8 1994 726-729
24. J.T. Reeves L.G. Moore R.E. McCullough R.G. McCullough G. Harrison B.I. Tranmer et al. Headache at high altitude is not related to internal carotid arterial blood velocity J Appl Physiol 59 3 1985 909-915
25. R.W. Baumgartner I. Spyridopoulos P. Bartsch M. Maggiorini O. Oelz Acute mountain sickness is not related to cerebral blood flow: A decompression chamber study J Appl Physiol 86 5 1999 1578-1582
26. L. Dumont C. Lysakowski M.R. Tramèr J.D. Junod C. Mardirosoff E. Tassonyi et al. Magnesium for the prevention and treatment of acute mountain sickness Clin Sci (Lond) 106 2004 269-277
27. C. Lysakowski E. Von Elm L. Dumont J. Junod E. Tassonyi B. Kayser et al. The effect of magnesium, high altitude and acute mountain sickness on blood flow velocity in the middle cerebral artery Clin Sci (Lond) 106 2004 279-285
28. A. Ter Minassian L. Beydon M. Ursino B. Gardette C. Gortan J.P. Richalet Doppler study of middle cerebral artery blood flow velocity and cerebral autoregulation during a simulated ascent of Mount Everest Wilderness Environ Med 12 3 2001 175-183
29. S.Y. Huang L.G. Moore R.E. McCullough R.G. McCullough A.J. Micco C. Fulco et al. Internal carotid and vertebral arterial flow velocity in men at high altitude J Appl Physiol 63 1 1987 395-400
30. M.J. Poulin P.A. Robbins Indexes of flow and cross-sectional area of the middle cerebral artery using doppler ultrasound during hypoxia and hypercapnia in humans Stroke 27 12 1996 2244-2250
31. C. Lysakowski B. Walder M.C. Costanza M.R. Tramèr Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: A systematic review Stroke 32 10 2001 2292-2298
32. C.M. Burch M.A. Wozniak M.A. Sloan M.I. Rothman D. Rigamonti T. Permutt et al. Detection of intracranial internal carotid artery and middle cerebral artery vasospasm following subarachnoid hemorrhage J Neuroimaging 6 1 1996 8-15